Polisano Pharmaceuticals


Polisano Pharmaceuticals, established in 2003, is a Romanian-capital business dedicated to researching, developing, manufacturing, and supplying high-quality medicines and dietary supplements both nationally and internationally. The company invests heavily in innovation, with over 70 million euros spent in the last decade on state-of-the-art production facilities and equipment. It operates with a focus on quality, automation, and sustainability, exporting to over 30 countries and producing more than 40 million units annually.

Industries

dietary-supplements
manufacturing
medical
pharmaceutical

Nr. of Employees

Very Large (1000+)

Polisano Pharmaceuticals


Products

Linistress (supplement)

Dietary supplement positioned for stress-related support; available in multiple presentation formats.

Melatonina (melatonin supplement)

Melatonin dietary supplement for sleep regulation.

Vitamina D3 2000 UI (vitamin D supplement)

Vitamin D3 supplement offering 2000 IU strength, available as consumer product.

Uribene (urinary health product)

Product listed under urinary/genitourinary product category.

Saruri de rehidratare (oral rehydration salts)

Oral rehydration salts product offered as a consumer rehydration solution.


Services

On-site pharmaceutical and supplement production and packaging services for third parties (inferred from site sections on production and services).

Formulation and development services for OTC medicines and dietary supplements across multiple therapeutic areas.

Expertise Areas

  • Pharmaceutical manufacturing
  • Nutritional supplement formulation
  • Quality assurance and product release
  • Regulatory compliance and pharmacovigilance
  • Show More (4)

Key Technologies

  • Automated pharmaceutical production lines
  • Blister packaging
  • Film-coated tablet manufacturing
  • High-throughput packaging and labeling
  • Show More (3)

News & Updates

Investment in Innovation

Over 70 million euros invested in modern production facilities and equipment over the last decade.

An article explaining the immune system's response to pathogens and the importance of immune support.

Major Investment Milestone

Invested over 70 million euros in production and research facilities.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.